BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/3/2023 7:09:27 AM | Browse: 72 | Download: 122
Publication Name World Journal of Clinical Cases
Manuscript ID 75182
Country United States
Category Endocrinology & Metabolism
Manuscript Type Retrospective Study
Article Title Hyperglycemia in COVID-19 infection without diabetes mellitus: Association with inflammatory markers
Manuscript Source Invited Manuscript
All Author List Harinivaas Shanmugavel Geetha, Garima Singh, Abinesh Sekar, Maya Gogtay, Yuvaraj Singh, GM Abraham and Nitin Trivedi
Funding Agency and Grant Number
Corresponding Author Yuvaraj Singh, MD, Chief Physician, Researcher, Internal Medicine, Saint Vincent Hospital, 123 Summer Street, Worcester, MA 01608, United States. yuvarajmle@gmail.com
Key Words COVID-19; Inflammatory markers; Hyperglycemia; C-reactive protein; Mortality; Severity; Mechanisms; Diabetes mellitus
Core Tip Our study suggests that there is no correlation between the inflammatory marker levels and the presence of hyperglycemia in non-diabetic patients with coronavirus disease 2019 (COVID-19) infection. With an increased need to understand the mechanism underlying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-induced hyperglycemia, we assessed the validity of the most accepted COVID-19 infection-induced cytokine storm-related stress hyperglycemia theory. However, our study did not show any correlation between inflammatory marker levels that correlate with the cytokine storm and the level of hyperglycemia. This suggests the possibility of other mechanisms playing a role in the SARS-CoV-2 infection-induced hyperglycemia. Our study also demonstrated that new-onset hyperglycemia was an independent risk factor for higher mortality and length of stay, thereby emphasizing the need to understand the mechanisms leading to hyperglycemia.
Citation Geetha HS, Singh G, Sekar A, Gogtay M, Singh Y, Abraham GM, Trivedi N. Hyperglycemia in COVID-19 infection without diabetes mellitus: Association with inflammatory markers. World J Clin Cases 2023; 11(6): 1287-1298
Received
2022-10-30 05:47
Peer-Review Started
2022-10-30 05:48
To Make the First Decision
Return for Revision
2022-11-28 04:46
Revised
2022-12-17 00:34
Second Decision
2023-02-03 03:20
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2023-02-03 07:09
Articles in Press
2023-02-03 07:09
Publication Fee Transferred
Edit the Manuscript by Language Editor
2023-01-13 01:32
Typeset the Manuscript
2023-02-14 15:14
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com